Earticle

현재 위치 Home

Review Article

우리나라의 다제약제 현황과 적정관리 방안에 대한 고찰
Reviews on the Current Status and Appropriate Management of Polypharmacy in South Korea

첫 페이지 보기
  • 발행기관
    한국임상약학회 바로가기
  • 간행물
    한국임상약학회지 KCI 등재 바로가기
  • 통권
    제28권 제1호 (2018.03)바로가기
  • 페이지
    pp.1-9
  • 저자
    박혜영, 손현순, 권진원
  • 언어
    한국어(KOR)
  • URL
    https://www.earticle.net/Article/A326674

※ 기관로그인 시 무료 이용이 가능합니다.

4,000원

원문정보

초록

영어
Polypharmacy is increasing owing to an increase in the elderly population and multimorbidities associated with the increased risk of administration of potentially inappropriate medications (PIMs). The negative effects of polypharmacy on various health conditions and aspects, such as fall, fracture, mortality, cognitive function, and dementia, have been reported. The management of excess and inappropriate polypharmacy through proper interventions and local or national guidelines has been highlighted. The purpose of polypharmacy management is to appropriately prescribe medicines that are essential to treat diseases in patients and to avoid inappropriate polypharmacy, such as interactive or duplicate medicines under prescription and PIMs for specific diseases. Community pharmacists in Australia, the EU, USA, and Japan are collaborating with prescribers to review medications to ensure that the patients can be prescribed appropriate medications. The service cost is reimbursed by public or private insurers. A study in the United States has shown that even with medication review costs, the overall medication cost has reduced. In Korea, various projects such as Drug Utilization Review service and safe use of medicines have been conducted; however, no national guidelines or management measures have been established. It is necessary to implement a national long-term plan on polypharmacy management. Furthermore, a phased implementation plan is required. Shortly, active medication review services and education programs for healthcare professionals with the support of the government should be considered in Korea with reference to other countries in order to raise awareness of seriousness and risks of inappropriate polypharmacy.

목차

ABSTRACT
 우리나라 및 해외의 다제약제 처방 현황
 다제약제 처방이 노인의 건강성과에 미치는 영향
 국내외 다제약제 처방 관리 지침 및 사례
 해외의 다제약제 관리 사례
  유럽
  호주
  캐나다
  미국
  일본
  우리나라
 결론
 감사의 말씀
 참고문헌

키워드

Polypharmacy the elderly potentially inappropriate medication

저자

  • 박혜영 [ Hae-Young Park | 경북대학교 약학대학 ]
  • 손현순 [ Hyun Soon Sohn | 차의과학대학교 약학대학 ]
  • 권진원 [ Jin-Won Kwon | 경북대학교 약학대학 ]

참고문헌

자료제공 : 네이버학술정보

간행물 정보

발행기관

  • 발행기관명
    한국임상약학회 [Korean College of Clinical Pharmacy]
  • 설립연도
    1
  • 분야
    의약학>약학
  • 소개
    합리적 약물치료(rational pharmacotherapy)의 보장 및 증진을 궁극목적으로 하며 이를 달성하기 위해 임상약학의 발전과 회원 상호간의 친목을 도모한다.

간행물

  • 간행물명
    한국임상약학회지 [Korean Journal of Clinical Pharmacy]
  • 간기
    계간
  • pISSN
    1226-6051
  • 수록기간
    1991~2026
  • 등재여부
    KCI 등재
  • 십진분류
    KDC 518 DDC 615

이 권호 내 다른 논문 / 한국임상약학회지 제28권 제1호

    피인용수 : 0(자료제공 : 네이버학술정보)

    함께 이용한 논문 이 논문을 다운로드한 분들이 이용한 다른 논문입니다.

      페이지 저장